Types segmentation delineates the chemical families that underpin market valuation. Inorganic arsenic compounds dominate, encompassing arsenates, arsenites, and arsenic trioxide, which together generate approximately 70% of total sales due to their extensive use across semiconductor, glass, and wood‑preservation applications. Within this group, arsenic trioxide alone commands a premium price because of its purity requirements for electronic doping. Organic arsenic compounds represent the remaining 30%, including arsenobetaine, arsenocholine, and therapeutic arsenicals such as arsenic trioxide formulations for leukemia treatment. Although niche, organic variants command higher margins owing to specialized pharmaceutical and research uses. The differentiation between inorganic and organic arsenic compounds clarifies cost structures, regulatory exposure, and growth trajectories, offering a precise market taxonomy essential for strategic planning and investment decisions.